Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2019-02-12 Regulatory Filings
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Moderna, Inc. It announces a press release about positive interim phase 1 data for a vaccine and mentions a forthcoming call to discuss results. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive financial analysis. The length is 3315 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. The document is primarily an announcement of a press release and a planned call, not a full earnings release or detailed financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-02-12 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content discusses a legal decision affecting the company's bylaws and forum provisions, which is an update on legal proceedings and governance matters. The document is relatively short (3685 characters) and does not contain financial statements or detailed financial data. It is not an annual or quarterly report, earnings release, or investor presentation. The primary focus is on a legal event and its implications for the company's governance documents. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2019-01-22 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 17, 2019, by Moderna, Inc. The key content is the announcement of the departure of John Mendlein, a senior officer, from the company effective February 1, 2019. It also mentions a press release about this departure. The main focus is on changes in the company's management personnel. There is no financial data or report content, only a management change announcement. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3752 characters, which is short and consistent with a Form 8-K management change notice. Therefore, the correct classification is MANG with high confidence.
2019-01-18 English
SC 13G/A Filing
Major Shareholding Notification
2019-01-10 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes references to a press release attached as Exhibit 99.1, which contains updates on the company's financial condition and corporate progress. The document does not contain detailed financial statements or comprehensive analysis typical of an Annual Report (10-K) or Interim Report (IR). Instead, it is a regulatory filing announcing recent developments and attaching a press release. The length is 6581 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2019-01-08 English
SC 13G Filing
Major Shareholding Notification
2018-12-21 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.